Effect of mycophenolate sodium in scleroderma-related interstitial lung disease (Q84865788)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 2011

edit

Language	Label	Description	Also known as
English	Effect of mycophenolate sodium in scleroderma-related interstitial lung disease	scientific article published on 01 September 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

title

Effect of mycophenolate sodium in scleroderma-related interstitial lung disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

main subject

interstitial lung disease

1 reference

based on heuristic

inferred from title

author

Albert Selva-O'Callaghan

series ordinal

4

object named as

Albert Selva-O'Callaghan

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21881859

retrieved

11 December 2024

author name string

Carmen Pilar Simeón-Aznar

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Vicent Fonollosa-Plá

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Carles Tolosa-Vilella

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Roser Solans-Laqué

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

Miquel Vilardell-Tarrés

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

21881859

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21881859

retrieved

11 December 2024

publication date

1 September 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

full work available at URL

http://link.springer.com/content/pdf/10.1007/s10067-011-1823-1.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

http://link.springer.com/article/10.1007/s10067-011-1823-1/fulltext.html

file format

HyperText Markup Language

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

http://link.springer.com/content/pdf/10.1007/s10067-011-1823-1

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

published in

Clinical Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

volume

30

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

page(s)

1393-1398

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

cites work

Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spirometric reference values from a Mediterranean population

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil and its mechanisms of action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL/lpr mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary function tests

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality in systemic sclerosis (scleroderma)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of mycophenolate mofetil in autoimmune and renal diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial lung disease in scleroderma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma lung disease: evolving understanding in light of newer studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21881859

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Journal of Rheumatology

series ordinal

2

volume

28

page(s)

2454

author name string

S Jacobsen

publication date

2001

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Quarterly Journal of Medicine

series ordinal

6

volume

298

page(s)

139

author name string

P Lee

publication date

1992

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Journal of Rheumatology

series ordinal

7

volume

20

page(s)

838

author name string

RM Silver

publication date

1993

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Journal of Rheumatology

series ordinal

12

volume

25

page(s)

1325

author name string

G Varai

publication date

1998

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Journal of Rheumatology

series ordinal

13

volume

29

page(s)

298

author name string

I Pakas

publication date

2002

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Journal of Rheumatology

series ordinal

14

volume

29

page(s)

731

author name string

R Giacomelli

publication date

2002

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Journal of Rheumatology

series ordinal

15

volume

29

page(s)

2371

author name string

B Griffiths

publication date

2002

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Journal of Rheumatology

series ordinal

16

volume

30

page(s)

1121

author name string

G Mittal

publication date

2003

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

series ordinal

33

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

The Journal of Rheumatology

series ordinal

34

volume

15

page(s)

202

author name string

EC LeRoy

publication date

1988

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

Bulletin europeen de physiopathologie respiratoire

series ordinal

36

volume

22

page(s)

217

author name string

J Roca

publication date

1986

1 reference

stated in

Crossref

DOI

10.1007/S10067-011-1823-1

reference URL

https://api.crossref.org/works/10.1007/S10067-011-1823-1

retrieved

11 December 2024

Identifiers

DOI

10.1007/S10067-011-1823-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

PubMed publication ID

21881859

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21881859

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21881859%20AND%20SRC:MED&resulttype=core&format=json

retrieved

12 February 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84865788&oldid=2285938452"